Medical Services

The chronic, hereditary condition known as cystic fibrosis (CF) mostly damages the digestive system and lungs. Mutations in the CFTR gene cause it; thick, sticky mucus produced by these changes attracts dangerous microorganisms and clogs airways. Recurrent lung infections, dyspnoea, and increasing lung damage follow from this. Often leading to poor development and malnutrition, mucus in the digestive tract blocks the pancreas, therefore preventing the production of enzymes required to break down food.
Though they vary, common CF symptoms are coughing constantly, frequent lung infections, wheezing, and trouble gaining weight. Early diagnosis made possible by neonatal screening and genetic testing has enhanced management and life expectancy as medical treatment advances. Treatment usually involves combining airway clearing methods, inhaled drugs, enzyme supplements, and, in severe situations, lung transplants.
Though a cure is not yet possible, many patients' treatment has been transformed by new treatments aiming at the fundamental genetic defect—like CFTR modulators. Furthermore, crucial in enhancing quality of life are lifestyle changes and thorough care strategies. For patients with this life-limiting illness, constant research and support are crucial in the search for a conclusive cure and improved treatments.